Fluorescence News and Research

RSS

n6 appoints Broad Institute Principal Investigator Aziz Al'Khafaji as Scientific Advisor, advancing AutoNorm™ as the new standard in NGS library preparation

n6 Tec, Inc. (n6), the developer of icon96™, the first and only intelligent thermocycler platform with real-time, per-well adaptive amplification (iconPCR™ with AutoNorm), today announced the appointment of Dr. Aziz Al'Khafaji as Scientific Advisor.

From n6 7 Jul 2026

n6 launches icon16™, expanding AutoNorm™ adaptive amplification to lower-throughput NGS workflows

In 2024, n6 introduced icon96™, redefining expectations for PCR amplification in NGS library preparation.

From n6 7 Jul 2026

Study compares different light therapies for treating Alzheimer's disease

The researchers treated 5‑month‑old 5xFAD mice – a model with aggressive amyloid deposition – with 810‑nm light (25 mW/cm² at the scalp, ~6.25 mW/cm² brain dose for CW, and half that for 40‑Hz due to 50% duty cycle) for 10 minutes daily over 37 days.

6 Jul 2026

Neutral lipids may act as functional medium for controlling supramolecular polymerization

The formation of supramolecular polymers within living cells is an emerging strategy for regulating cellular functions, and lipid droplets (LDs) are promising environments for such processes.

6 Jul 2026

New high-throughput biological sensors track cellular lipid molecules

Inside every cell are lipid molecules that make up cellular membranes, helping organelles communicate and respond to stress.

2 Jul 2026

Achieve precise, noncontact tissue ablation at low power levels

445 nm diode lasers have already been used successfully and safely for cholesteatoma surgery.

30 Jun 2026

FluoGuide announces positive results from Phase 2 oral head and neck cancer trial

FluoGuide A/S, a biotech company maximizing surgical outcomes in oncology by lighting up cancer, today announced positive results from the first part of its ongoing FG001-CT-005 Phase 2 trial evaluating FG001 for surgical guidance in patients with oral head and neck cancer.

30 Jun 2026

Advancing 3D imaging, automation, and phenotypic discovery with AI-driven high-content screening

Discover how AI-driven high-content screening improves 3D imaging, segmentation, and automation.

From Molecular Devices UK Ltd 29 Jun 2026

Gene fusion patterns refine classification of rare acute leukemias

Acute leukemias with chimeric fusion genes involving FET (FUS, EWSR1, and TAF15) family proteins and ETS (E26 transformation-specific)-like transcription factors often present with unique clinical and pathological characteristics.

27 Jun 2026

New accessible multiplex imaging workflow advances spatial liver research

Spatial biology technologies are reshaping modern biomedical research by enabling the visualization of cellular organization and interactions within intact tissues.

26 Jun 2026

AI and multiomics reveal how gut bacteria trigger colon cancer

Over the past two decades, high‑throughput sequencing has dramatically expanded our understanding of the gut microbiome's composition.

26 Jun 2026

New miniature microscope stably images brain cells during movement

Researchers at Peking University have developed DUET, a breakthrough dual-color miniature two-photon microscope that overcomes two persistent barriers in neuroscience imaging: motion-induced signal instability and fluorescence channel crosstalk.

22 Jun 2026

New optical technique uses light to reveal internal contents of chicken eggs

Scientists have demonstrated a non-invasive technique that uses light to reveal the hidden contents of chicken eggs, potentially helping to curb the meat industry's practice of killing billions of male chicks at birth.

19 Jun 2026

Study shows jumping genes can transfer between different species

Genes are not passed on exclusively from parents to their offspring. Some are mobile and can also jump to other species, as researchers at the Max Planck Institute for Marine Microbiology in Bremen have now shown.

19 Jun 2026

New CellTrap technology reveals how single immune cells attack brain tumors

Established laboratory tests mainly capture average values across many cells and show, for example, how many cancer cells survive after contact with immune cells.

18 Jun 2026

New single-protein analysis technique provides unprecedented information on scramblases

A new single-protein analysis technique gives researchers an unprecedented ability to study proteins called scramblases, which have critical roles in biology.

16 Jun 2026

New DNA tetrahedron nanostructures improve targeted cancer therapy delivery

Conventional cancer treatments, such as chemotherapy, often lack specificity and can damage both cancerous and healthy cells, leading to severe side effects.

10 Jun 2026

New platform identifies barriers to therapeutic antibody delivery in solid tumors

Eben Rosenthal, MD, the Barry and Amy Baker Professor and Chair of the Department of Otolaryngology-Head and Neck Surgery at Vanderbilt Health, is the senior author of the paper. Rosenthal and co-author Guolan Lu, PhD, of Stanford University School of Medicine, developed single-cell spatial pharmacobiology (SSP), an experimental and analytical platform that allows visualization of drug-tumor interactions in human solid tumors.

3 Jun 2026

New PET imaging platform improves osteosarcoma surgery precision

A new end-to-end PET imaging approach for osteosarcoma can rapidly and reliably distinguish tumor tissue from normal tissue and accurately assess surgical margins in real time.

2 Jun 2026

New funding supports cutting-edge research to combat cancers across South Texas

The University of Texas at San Antonio (UT San Antonio) and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of Texas (CPRIT) to further its mission of combating cancers across South Texas.

2 Jun 2026